Understanding COVID-19, Genome, Epidemiology, Diagnosis, Treatment, and Vaccination
Mostafa, E., El-Sawah, A., Magdy, E., Sayed, A., El-Azab, S., Natei, A., Husein, A., Hassan, S., Mostafa, M., Omran, M. (2020). Understanding COVID-19, Genome, Epidemiology, Diagnosis, Treatment, and Vaccination. EKB Journal Management System, 6(3), 98-120. doi: 10.21608/jbaar.2020.106102
Eslam Mostafa; Aisha El-Sawah; Esraa Magdy; Ahmed Sayed; Safaa El-Azab; Ayman Natei; Asmaa Husein; Salma Hassan; Menna Mostafa; Mohamed M. Omran. "Understanding COVID-19, Genome, Epidemiology, Diagnosis, Treatment, and Vaccination". EKB Journal Management System, 6, 3, 2020, 98-120. doi: 10.21608/jbaar.2020.106102
Mostafa, E., El-Sawah, A., Magdy, E., Sayed, A., El-Azab, S., Natei, A., Husein, A., Hassan, S., Mostafa, M., Omran, M. (2020). 'Understanding COVID-19, Genome, Epidemiology, Diagnosis, Treatment, and Vaccination', EKB Journal Management System, 6(3), pp. 98-120. doi: 10.21608/jbaar.2020.106102
Mostafa, E., El-Sawah, A., Magdy, E., Sayed, A., El-Azab, S., Natei, A., Husein, A., Hassan, S., Mostafa, M., Omran, M. Understanding COVID-19, Genome, Epidemiology, Diagnosis, Treatment, and Vaccination. EKB Journal Management System, 2020; 6(3): 98-120. doi: 10.21608/jbaar.2020.106102

Understanding COVID-19, Genome, Epidemiology, Diagnosis, Treatment, and Vaccination

Journal of Bioscience and Applied Research
Article 1, Volume 6, Issue 3, September 2020, Page 98-120  XML PDF (972.79 K)
Document Type: Original Article
DOI: 10.21608/jbaar.2020.106102
View on SCiNiTO View on SCiNiTO
Authors
Eslam Mostafa1; Aisha El-Sawah* 1; Esraa Magdy1; Ahmed Sayed1; Safaa El-Azab1; Ayman Natei1; Asmaa Husein1; Salma Hassan1; Menna Mostafa2; Mohamed M. Omran3
1Biotechnology/Bimolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt Giza, 12613, Egypt
2Molecular Biotechnology Program, Chemistry Department, Faculty of Science, Helwan University, Helwan, Egypt Ain Helwan, 11795, Cairo, Egypt
3Chemistry Department, Faculty of Science, Helwan University, Helwan, Egypt Ain Helwan, 11795, Cairo, Egypt
Abstract
In December 2019, an acute respiratory disease called COVID-19 from the coronavirus family has spread in Wuhan city in China. Due to the fast transmission of this disease and the number of cases increase, it received the whole world’s attention. And on 30 January 2020, the World Health Organization (WHO) officially announced that COVID-19 is epidemic. In March, WHO declared that it is pandemic due to the high number of cases confirmed globally. SARS-CoV-2, that has single-stranded (positive-sense) RNA with structural proteins (S, E, M, N), has common manifestations like dry cough, fever, and fatigue as the common cold. These symptoms range from moderate to severe that cause death, even there are also asymptomatic patients. The SARS-CoV-2 virus can be transmitted through person-to-person transmission. Though there are two different ways for its entry to the host cell, which are endosomal or plasma membrane fusion, both require ACE2 receptor attachment. There are different diagnostic techniques for SARS-CoV-2 ranging from RT-PCR and Immuno-tests to advanced methods such as CT and crisper technology. No therapies to COVID-19 have been developed so far, but researchers are currently working on developing therapies specific to this novel coronavirus. Furthermore, many of the repurposed drugs that have the potential to either attenuate the symptoms or prevent the viral entry/replication are still in preclinical and clinical trial phases. Besides the vaccination that has been developed whether they are live attenuated, subunit, or nucleic acid vaccines.
Keywords
COVID-19; Diagnosis; Epidemiology; Structure; Treatment; Vaccine
Statistics
Article View: 692
PDF Download: 460